Relationship of paraoxonase-1 and paraoxonase-3 with routine laboratory tests and oxidative stress in type 2 diabetes mellitus
Open Access
- 19 September 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (5) , 691-697
Abstract
Objectives: We aimed to investigate the relationship between serum paraoxonase-1 (PON1) and paraoxonase-3 (PON3) levels and activities with hemoglobin A1c (HbA 1c ), serum fasting blood glucose, lipid profile, and oxidative stress in patients with type 2 diabetes mellitus (T2DM). Also, we aimed to examine PON1 and PON3 levels and activities in these patients according to the HbA 1c goal in diabetes treatment and PON1 192 phenotypes. Methods: One hundred forty-one volunteers diagnosed with T2DM participated in this study. Serum PON1 and PON3 levels and activities, total oxidant status (TOS), and total antioxidant status (TAS) were measured. PON1 192 phenotypes were determined by using PON1 activities. Also, HbA 1c , serum fasting blood glucose, and lipid profile results, which were measured for routine examination on the same day as sample collection, were used for this study. Results: There was a positive relationship between arylesterase and lactonase activities and high-density lipoprotein cholesterol (HDL-C), between lactonase activity and TAS, and a negative relationship between PON1 level and TAS in patients with T2DM. Our study also showed that PON3/HDL-C was higher in patients with HbA 1c levels ≥7 %. Lactonase activities were higher in patients with PON1 Q192Q and PON1 Q192R phenotypes than in patients with PON1 R192R phenotypes. Conclusions: PON1 and PON3 levels and activities alone could not be associated with immediate or long-term blood glucose levels in patients with T2DM. Higher PON3/HDL-C in patients with HbA 1c levels ≥7 % may show a protective role of PON3 in defense against higher glucose levels. Also, we found that the PON1 192 phenotype can affect serum lactonase activity.Keywords
Funding Information
- Trakya University Scientific Research Projects Unit (TÜBAP 2021/79)
This publication has 42 references indexed in Scilit:
- Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 StudyDiabetologia, 2023
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022
- Paraoxonase‐1 (PON1) Status Analysis Using Non‐Organophosphate SubstratesCurrent Protocols, 2021
- In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional studyDiabetologia, 2019
- ROS-mediated glucose metabolic reprogram induces insulin resistance in type 2 diabetesBiochemical and Biophysical Research Communications, 2016
- Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetesClinica Chimica Acta, 2015
- The three-gene paraoxonase family: Physiologic roles, actions and regulationAtherosclerosis, 2011
- Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemiaClinical and Experimental Medicine, 2007
- Lipid profile, oxidant–antioxidant status and glycoprotein components in hyperlipidemic patients with/without diabetesClinica Chimica Acta, 2005
- Pharmacogenetics of paraoxonases: a brief reviewNaunyn-Schmiedeberg's Archives of Pharmacology, 2004